BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30220323)

  • 1. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
    Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
    Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
    Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
    Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
    Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
    Kong C; Zhu XZ; Lee TF; Feng PB; Xu JH; Qian PD; Zhang LF; He X; Huang SF; Zhang YQ
    Sci Rep; 2016 May; 6():26378. PubMed ID: 27210263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China.
    Wen DW; Lin L; Mao YP; Chen CY; Chen FP; Wu CF; Huang XD; Li ZX; Xu SS; Kou J; Yang XL; Ma J; Sun Y; Zhou GQ
    Radiother Oncol; 2021 Apr; 157():99-105. PubMed ID: 33484752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis.
    Sun Y; Zhou GQ; Qi ZY; Zhang L; Huang SM; Liu LZ; Li L; Lin AH; Ma J
    BMC Cancer; 2013 Aug; 13():397. PubMed ID: 23978128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal Tissue Complication Probability Model for Radiation-induced Temporal Lobe Injury after Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
    Zeng L; Huang SM; Tian YM; Sun XM; Han F; Lu TX; Deng XW
    Radiology; 2015 Jul; 276(1):243-9. PubMed ID: 25658039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
    Li Y; Xu T; Qian W; Lu X; Hu C
    Oral Oncol; 2018 Sep; 84():1-6. PubMed ID: 30115466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
    Fan X; Huang Y; Xu P; Min Y; Li J; Feng M; Xu G; Lang J
    BMC Cancer; 2022 Feb; 22(1):178. PubMed ID: 35177030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.
    Liu S; Lu T; Zhao C; Shen J; Tian Y; Guan Y; Zeng L; Xiao W; Huang S; Han F
    J Neurooncol; 2014 Sep; 119(2):421-8. PubMed ID: 24986091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
    Wu L; Chung YL
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis.
    Dong J; Ng WT; Wong CHL; Li JS; Bollen H; Chow JCH; Eisbruch A; Lee AWM; Lee VHF; Ng SP; Nuyts S; Smee R; Ferlito A
    Radiother Oncol; 2024 Jun; 195():110258. PubMed ID: 38537680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
    Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
    Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy.
    Zhou GQ; Yu XL; Chen M; Guo R; Lei Y; Sun Y; Mao YP; Liu LZ; Li L; Lin AH; Ma J
    PLoS One; 2013; 8(7):e67488. PubMed ID: 23874422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma.
    Su SF; Huang Y; Xiao WW; Huang SM; Han F; Xie CM; Lu TX
    Radiother Oncol; 2012 Sep; 104(3):312-6. PubMed ID: 22857858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy.
    Wang J; Miao Y; Ou X; Wang X; He X; Shen C; Ying H; Hu W; Hu C
    Radiat Oncol; 2019 Mar; 14(1):42. PubMed ID: 30866964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z; Zhang Z; Luo J; Li N; Peng X
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic variables for temporal lobe injury after intensity modulated-radiotherapy of nasopharyngeal carcinoma.
    Feng M; Huang Y; Fan X; Xu P; Lang J; Wang D
    Cancer Med; 2018 Mar; 7(3):557-564. PubMed ID: 29473319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.